Global Cell Culture Media Market: Country Overview; Recent Events; Value Chain Analysis; Production Process; Price Analysis; Indicator Analysis; Market Dynamics: Drivers & Constraints, Innovations & Trends, SWOT Analysis, Porter’s Five Forces; Industry Best Practices: Sourcing Strategy, Procurement Model, Key Factors Influencing the Quotation; Key Supplier Analysis, 2024-2032

Cell Culture Media Industry Report by Regional Category Spend, Price Analysis, Key Demand, and Price Indicators, and Best Buying Practices

The global Cell Culture Media market reached a value of about USD 1970 million in 2021. The industry is projected to grow at a CAGR of around 7.5% in the forecast period of 2022-2027 to reach a value of about USD 3041 million by 2027.

The global Cell Culture Media industry report gives a comprehensive analysis of the industry, including key segments, trends, drivers, restraints, the competitive landscape, and other essential market aspects. The growing research and development in the sector are primarily driving the market growth. The Asia Pacific is the highest category spender by region, driving the demand for the Cell Culture Media industry.

Industry Definition and Segmentation

Cell culture mediums are made up of a blend of chemicals and nutrients that promote cellular development. It refers to removing cells, tissues, or organs from animals or plants and placing them in an artificial environment that supports their survival and multiplication. Cell cultures require media, or nutritional growth ingredients, to develop and survive in their incubation environment.

The Cell Culture Media industry report comprises segments by form (liquid media and solid/powder media), group (standard Basil media and custom media), composition (chemically defined media and serum-based media) and region (North America, Europe, Asia Pacific, the Middle East and Africa, and South America).

The Asia Pacific Region is Driving the Growth of the Industry

The Asia Pacific holds the largest share in the industry due to increased research and development expertise in the field of cell culture medium. The market for advanced stem cell treatments will continue to rise in this area.

The market is being driven by the rise in the number of chronic diseases, which further leads to improved research infrastructure and cell-based research policy. The advantages of the process, including shorter lead times and the capacity to create vaccines in more significant numbers on demand, and that cell culture-based vaccinations may be kept for extended periods, are furthering the industry’s expansion. As a result, cell-based vaccinations have become increasingly popular in recent years, prompting significant corporations to try to cash in on the prospects. Also, the Increased applications of gene treatments and growth in the number of cancer research initiatives are likely to impact the market positively.

Best Procurement Practices

The global Cell Culture Media industry report by Procurement Resource gives an in-depth analysis of the best buying practices followed by primary global Cell Culture Media regions, such as engagement models, contract terms, and buyer and supplier negotiation levers.

Category Management Studies

Agar is frequently used in microbial cultures for growth plates or liquid systems. Agar is available in liquid and powder forms, with added nutrients for optimum development. Because established cell lines, stem cells, and primordial cells require different nutrients, the media for each kind varies from simple to complex. Depending on the culture attachment or development stage, primary neuronal cultures need specialised media and additional supplies. Amino acids, Vitamins, Carbohydrates, Inorganic salts, Basic and trace elements, Serum, Hormones, Buffering systems, Supplements, and Antibiotics are all standard components of the cell culture medium.

Growing R&D Activities in the Sector, Further Driving the Cell Culture Media Market

The industry is witnessing growth due to the rising R&D spending in pharmaceutical companies. In addition, increased demand for vaccines and monoclonal antibodies is likely to propel the cell culture media market forward. Cell culture media market growth potential is being bolstered by increased attention and investment in research and development capabilities in cell-based research. The need for a cell culture medium has been boosted by advances in genetic engineering, genomic and proteomic analysis, and recombinant DNA technologies. The market is being propelled by the development of innovative three-dimensional Cell Culture techniques and the rising need for these techniques in biopharmaceutical research and vaccine manufacturing. The demand for innovative 3D cell culturing techniques and Cell Cultures is expected to be driven by advances in proteomic gene expression and the development of novel vaccines and biopharmaceuticals. As a result, the industry is expanding.

The regional markets for the industry can be divided into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific.

Key Industry Players Mentioned in the Cell Culture Media Industry Report

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Cytiva Life Sciences
• Fujifilm Irvine Scientific, Inc.
• Lonza Group Ltd.

Market Landscape

With multiple prominent competitors, the culture media market is relatively competitive. Few large competitors are currently dominating the industry in terms of market share. Furthermore, the advantages of 3D cell cultures have enticed several companies to invest in this area. Microfluidic organ-on-a-chip models, which are 3D microfluidic cell culture chips built to replicate the physiology of an organ, have also gotten a lot of attention. Various 3D cell culture firms are obtaining money from venture capitalists to speed up the marketing and distribution of their goods. In the following years, such initiatives by investors and industry participants are projected to provide considerable development prospects for market players.

Key Initiatives by Companies

• The Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which facilitates the large-scale development and culture of functional natural killer (NK) cells with or without the assistance of feeder cells, was released in October 2021 by Thermo Fisher Scientific Inc. (US).
• In September 2020, Thermo Fisher Scientific opened a new bioprocessing collaboration centre in St. Louis, Missouri.